Breaking the in vitro barrier in respiratory medicine: Engineered microphysiological systems for chronic obstructive pulmonary disease and beyond

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 7, 2018, Pages 869-875

  Benam, Kambez H ^a,b   Königshoff, Melanie ^a   Eickelberg, Oliver ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b The University of Colorado Denver   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIGARETTE SMOKE; CYTOKINE;

AIRWAY EPITHELIUM CELL; BIOENGINEERING; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; LUNG EPITHELIUM; MECHANICAL STRESS; MICROFLUIDICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL CULTURE TECHNIQUE; DEVICES; DISEASE MODEL; MOUSE; PATHOPHYSIOLOGY; PROCEDURES; PULMONOLOGY;

ANIMALS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HUMANS; IN VITRO TECHNIQUES; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE;

EID: 85045210966     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201709-1795PP     Document Type: Review

References (38)

1. World Health Organization. The top 10 causes of death; Fact sheet No. 310-updated January 2017. Geneva: World Health Organization; 2017.
2. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance-United States, 1999-2011. Chest 2013;144:284-305.
3. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, et al.; ATS/ERS Task Force for COPD Research. An Official American Thoracic Society/European Respiratory Society Statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;191:e4-e27.
4. Hyde DM, Hamid Q, Irvin CG. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J Allergy Clin Immunol 2009;124(6 Suppl):S72-S77.
5. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159-175.
6. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295:L1-L15.
7. Benam KH, Villenave R, Lucchesi C, Varone A, Hubeau C, Lee HH, et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods 2016;13:151-157.
8. Vandivier RW, Ghosh M. Understanding the relevance of the mouse cigarette smoke model of COPD: peering through the smoke. Am J Respir Cell Mol Biol 2017;57:3-4.
9. Hecht SS. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis 2005;26:1488-1492.
10. Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang KJ, et al. Engineered in vitro disease models. Annu Rev Pathol 2015;10:195-262.
11. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol 2014;32:760-772.
12. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science 2010;328:1662-1668.
13. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012;4:159ra147.
14. Nalayanda DD, Puleo C, Fulton WB, Sharpe LM, Wang TH, Abdullah F. An open-access microfluidic model for lung-specific functional studies at an air-liquid interface. Biomed Microdevices 2009;11:1081-1089.
15. Douville NJ, Zamankhan P, Tung YC, Li R, Vaughan BL, Tai CF, et al. Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab Chip 2011;11:609-619.
16. Zhang C, Zhao Z, Abdul Rahim NA, van Noort D, Yu H. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 2009;9:3185-3192.
17. Jain A, Barrile R, van der Meer AD, Mammoto A, Mammoto T, De Ceunynck K, et al. Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics. Clin Pharmacol Ther 2017;103:332-340.
18. Huh D, Fujioka H, Tung YC, Futai N, Paine R III, Grotberg JB, et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc Natl Acad Sci U S A 2007;104:18886-18891.
19. Tavana H, Zamankhan P, Christensen PJ, Grotberg JB, Takayama S. Epithelium damage and protection during reopening of occluded airways in a physiologic microfluidic pulmonary airway model. Biomed Microdevices 2011;13:731-742.
20. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
21. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343:269-280.
22. McDonough JE, Yuan R, Suzuki M, Seyednejad N, ElliottWM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-1575.
23. Benam KH, Mazur M, Choe Y, Ferrante TC, Novak R, Ingber DE. Human lung small airway-on-a-chip protocol. Methods Mol Biol 2017;1612:345-365.
24. Vlahos R, Bozinovski S. Recent advances in pre-clinical mouse models of COPD. Clin Sci (Lond) 2014;126:253-265.
25. Benam KH, Novak R, Nawroth J, Hirano-Kobayashi M, Ferrante TC, Choe Y, et al. Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip. Cell Syst 2016;3:456-466.e4.
26. Uhl FE, Vierkotten S, Wagner DE, Burgstaller G, Costa R, Koch I, et al. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J 2015;46:1150-1166.
27. Switalla S, Lauenstein L, Prenzler F, Knothe S, Fö rster C, Fieguth HG, et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol 2010;246:107-115.
28. Lauenstein L, Switalla S, Prenzler F, Seehase S, Pfennig O, Fö rster C, et al. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro 2014;28: 588-599.
29. Oenema TA, Maarsingh H, Smit M, Groothuis GM, Meurs H, Gosens R. Bronchoconstriction induces TGF-b release and airway remodelling in guinea pig lung slices. PLoS One 2013;8:e65580.
30. Camacho DM, Collins JJ. Systems biology strikes gold. Cell 2009;137: 24-26.
31. Rajagopalan P, Kasif S, Murali TM. Systems biology characterization of engineered tissues. Annu Rev Biomed Eng 2013;15:55-70.
32. Sun X, Su J, Bao J, Peng T, Zhang L, Zhang Y, et al. Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. Biomaterials 2012;33:8265-8276.
33. Henry OYF, Villenave R, Cronce MJ, Leineweber WD, Benz MA, Ingber DE. Organs-on-chips with integrated electrodes for trans-epithelial electrical resistance (TEER) measurements of human epithelial barrier function. Lab Chip 2017;17:2264-2271.
34. Kolesky DB, Homan KA, Skylar-Scott MA, Lewis JA. Three-dimensional bioprinting of thick vascularized tissues. Proc Natl Acad Sci U S A 2016;113:3179-3184.
35. Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater 2014;26:3124-3130.
36. Colosi C, Shin SR, Manoharan V, Massa S, Costantini M, Barbetta A, et al. Microfluidic bioprinting of heterogeneous 3D tissue constructs using low-viscosity bioink. Adv Mater 2016;28:677-684.
37. Seo J, Conegliano D, Farrell M, Cho M, Ding X, Seykora T, et al. A microengineered model of RBC transfusion-induced pulmonary vascular injury. Sci Rep 2017;7:3413.
38. Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care 2007;11:R63.